Hypercalcemia in cancer: response to therapy.
D000230:Adenocarcinoma / Q000188:drug therapy; D000328:Adult; D000493:Allopurinol / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002118:Calcium / Q000097:blood; D003520:Cyclophosphamide / Q000627:therapeutic use; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D006934:Hypercalcemia / Q000188:drug therapy* / Q000628:therapy; D007680:Kidney Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D008113:Liver Neoplasms / Q000188:drug therapy; D008175:Lung Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D008223:Lymphoma / Q000188:drug therapy / Q000532:radiotherapy; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications* / Q000188:drug therapy; D008926:Plicamycin / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D014750:Vincristine; D000493:Allopurinol; D003520:Cyclophosphamide; D008926:Plicamycin; D002118:Calcium; D005472:Fluorouracil